AstraZeneca CEO Pascal Soriot is stepping down from the CSL board of directors by mutual agreement because the UK company's acquisition of Alexion creates a potential future conflict of strategic interest. …
Alexion acquisition means the end for AZ CEO on CSL board
January 27, 2021 Latest NewsBioPharmaBioPharmaDispatch Executive
Latest Video
New Stories
-
Medtech investment event unites investors and innovators to boost sector growth
May 5, 2025 - - Australian Biotech -
Mark Butler straight back to work as focus turns to issues and policy commitments
May 5, 2025 - - Latest News -
Neurotech says NTI164 shows positive tolerability in key preclinical toxicology studies
May 5, 2025 - - Australian Biotech -
Positive trial result for Immutep’s 'efti' in combination with MSD's anti-PD-1 therapy
May 5, 2025 - - Australian Biotech -
Arovella options advances Baylor College of technology to enhance iNKT cell platform
May 5, 2025 - - Australian Biotech -
FDA grants fast track designation for Alterity's ATH434 to treat multiple system atrophy
May 5, 2025 - - Australian Biotech -
New immune therapy treatment option for women diagnosed with advanced endometrial cancer
May 4, 2025 - - Latest News